Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH
Phase 1
Recruiting
- Conditions
- Non-alcoholic Steatohepatitis
- Interventions
- Other: Placebo (B)Drug: INI-822 (A)
- First Posted Date
- 2023-07-14
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Inipharm Australia Pty Ltd
- Target Recruit Count
- 104
- Registration Number
- NCT05945537
- Locations
- 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
News
No news found